At Interprotein, we are dedicated in the early stage drug discovery particularly focusing on PPIs as therapeutic targets. Our strategy for the discovery of novel small- and middle-sized molecules that modulate PPIs is aided by two unique technologies. We are also taking a step forward into a new dimension of drug discovery, integrating artificial intelligence (AI) into our technology to expedite drug development processes.